Understanding Higher Risk Mds And

This session is suitable for patients, family members, and caregivers who are living with a diagnosis of

To learn

Presented by Dale Schaar, MD, PhD, dhis session will provide a comprehensive overview of

Dr Vu Duong explains

On December 15th 2022, Dr Pramila Krishnamurthy, consultant haematologist at King's College Hospital, London and her ...

Andrew Brunner, MD, of Massachusetts General Hospital, Boston, MA, describes the treatment protocol for

Shahram Kordasti, MSc, MD, PhD, King's College London, London, UK, discusses the role of the immune system in ...

Webinar lead by Dr Michelle Geddes on January 18, 2022 Dr. Michelle Geddes, FRCPC Learning objectives: Not all

Learn

The 2022 updates of international guidelines affect diagnosis, classification and management of HR-

Drorit Merkel, MD, Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel, discusses the unmet need for novel ...

Lionel Ades, MD, PhD, Avicenne Hospital, Bobigny, France, outlines the current challenges facing

Eunice Wang, MD of Roswell Park Comprehensive Cancer Center explains the challenges of living with

This session is designed for newly diagnosed

David Sallman, MD, Moffit Cancer Center, Tampa, FL, describes the mechanism of action of magrolimab, and reports the final ...

Panelists Mikkael A. Sekeres, MD, MS; Jamile Shammo, MD; and Rami S. Komrokji, MD, discuss goals of therapy for patients with ...

During the EHA 2022 Congress, the

During the Society of Hematologic Oncology (SOHO) 2021 Annual Meeting, the

In this webinar Dr. Patel will provide an overview of

In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August ...